DLA
TMO icon

Douglas Lane & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Douglas Lane & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111M Buy
221,679
+3,382
+2% +$1.62M 1.51% 14
2026
Q1 		$107M Buy
218,297
+228
+0.1% +$124K 1.55% 13
2025
Q4 		$126M Buy
218,069
+1,793
+0.8% +$1.01M 1.73% 8
2025
Q3 		$105M Buy
216,276
+16,745
+8% +$7.79M 1.46% 15
2025
Q2 		$80.9M Buy
199,531
+12,333
+7% +$5.16M 1.17% 23
2025
Q1 		$93.1M Buy
187,198
+4,687
+3% +$2.54M 1.37% 19
2024
Q4 		$94.9M Buy
182,511
+3,460
+2% +$1.9M 1.34% 18
2024
Q3 		$111M Sell
179,051
-3,291
-2% -$1.95M 1.52% 14
2024
Q2 		$101M Sell
182,342
-766
-0.4% -$439K 1.43% 13
2024
Q1 		$106M Sell
183,108
-2,803
-2% -$1.57M 1.5% 14
2023
Q4 		$98.7M Buy
185,911
+1,836
+1% +$889K 1.52% 11
2023
Q3 		$93.2M Sell
184,075
-2,500
-1% -$1.33M 1.56% 15
2023
Q2 		$97.3M Sell
186,575
-8,584
-4% -$4.63M 1.57% 13
2023
Q1 		$112M Sell
195,159
-6,717
-3% -$3.79M 1.87% 6
2022
Q4 		$111M Sell
201,876
-12,053
-6% -$6.39M 1.86% 5
2022
Q3 		$109M Sell
213,929
-8,701
-4% -$4.87M 2% 4
2022
Q2 		$121M Sell
222,630
-7,961
-3% -$4.38M 2.05% 4
2022
Q1 		$136M Sell
230,591
-9,315
-4% -$5.35M 1.92% 7
2021
Q4 		$160M Sell
239,906
-10,351
-4% -$6.46M 2.13% 5
2021
Q3 		$143M Sell
250,257
-6,212
-2% -$3.41M 2.05% 8
2021
Q2 		$129M Sell
256,469
-1,722
-0.7% -$812K 1.81% 11
2021
Q1 		$118M Sell
258,191
-6,253
-2% -$2.98M 1.83% 8
2020
Q4 		$123M Sell
264,444
-13,331
-5% -$6.25M 2.06% 5
2020
Q3 		$123M Sell
277,775
-11,313
-4% -$4.67M 2.43% 4
2020
Q2 		$105M Sell
289,088
-12,254
-4% -$4.11M 2.25% 8
2020
Q1 		$85.5M Sell
301,342
-17,202
-5% -$5.42M 2.25% 8
2019
Q4 		$103M Sell
318,544
-5,536
-2% -$1.68M 1.92% 9
2019
Q3 		$94.4M Sell
324,080
-8,985
-3% -$2.57M 1.88% 10
2019
Q2 		$97.8M Sell
333,065
-7,607
-2% -$2.1M 1.91% 8
2019
Q1 		$93.2M Sell
340,672
-5,773
-2% -$1.44M 1.93% 8
2018
Q4 		$77.5M Sell
346,445
-3,424
-1% -$803K 1.83% 10
2018
Q3 		$85.4M Buy
349,869
+611
+0.2% +$141K 1.68% 12
2018
Q2 		$72.3M Sell
349,258
-4,093
-1% -$869K 1.53% 19
2018
Q1 		$73M Sell
353,351
-4,105
-1% -$862K 1.59% 15
2017
Q4 		$67.9M Sell
357,456
-9,088
-2% -$1.74M 1.43% 24
2017
Q3 		$69.3M Sell
366,544
-10,156
-3% -$1.84M 1.59% 15
2017
Q2 		$65.7M Buy
376,700
+9
+0% +$1.51K 1.55% 18
2017
Q1 		$57.9M Buy
376,691
+10,591
+3% +$1.62M 1.44% 22
2016
Q4 		$51.7M Buy
366,100
+1,772
+0.5% +$261K 1.32% 24
2016
Q3 		$58M Sell
364,328
-9,916
-3% -$1.53M 1.55% 17
2016
Q2 		$55.3M Sell
374,244
-8,470
-2% -$1.25M 1.59% 14
2016
Q1 		$54.2M Buy
+382,714
New +$51.3M 1.48% 17

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Douglas Lane & Associates's TMO Position: Q2 2026 in Review

Douglas Lane & Associates increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q2 2026, buying an estimated $1.62M and bringing the position to 221,679 shares worth $111M. The position accounts for 1.51% of the portfolio, ranked #14.

Douglas Lane & Associates first reported a position in TMO in Q1 2016 and has held it in 42 quarters since. The position peaked at $160M in Q4 2021. 1,085 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Douglas Lane & Associates held 221,679 shares of Thermo Fisher Scientific worth $111M as of Q2 2026.
  • Douglas Lane & Associates bought 3,382 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.62M.
  • Thermo Fisher Scientific made up 1.51% of Douglas Lane & Associates's portfolio in Q2 2026, its #14 holding.
  • Douglas Lane & Associates first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 42 quarters since.
  • Douglas Lane & Associates's Thermo Fisher Scientific position peaked at $160M in Q4 2021.
  • 1,085 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.